# Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

> **NCT00152932** · NA · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 17 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Dorzolamide 2% drops
- **DEVICE:** HRF and CLBF

## Key facts

- **NCT ID:** NCT00152932
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2007-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152932, "Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00152932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*